Pharma & Healthcare
Global Carbapenem Drugs Market Research Report 2024
- Mar 19, 24
- ID: 137093
- Pages: 106
- Figures: 233
- Views: 8
Carbapenem antibacterial drugs have a broad antibacterial spectrum and strong antibacterial activity. They have antibacterial effects on both aerobic and anaerobic bacteria, especially on multi-drug resistant Gram-negative bacilli, such as extended-spectrum β-lactamase-producing ( ESBL) Enterobacteriaceae bacteria have strong antibacterial activity. This type of drug has a wide range of clinical indications and plays an important role in the antibacterial treatment of multi-drug-resistant bacterial infections, mixed infections of aerobic and anaerobic bacteria, severe infections and infections in patients with immunodeficiency.
The global Carbapenem Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carbapenem Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carbapenem Drugs include Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical and Hospira Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem Drugs.
Report Scope
The Carbapenem Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shandong New Era Pharmaceutical
Shenzhen Haibin Pharmaceutical
Sinopharm Guorui Pharmaceutical
Taiwan Biotech Co., Ltd.
Merck
Sun Pharmaceutical Industries Ltd.
JW Pharmaceutical
Zhengde Pharmaceutical
Hospira Inc.
WG Critical Care
Hanhui Pharmaceutical
Zhuhai United Laboratories
ACS Dobfar S.p.A
Iterum Therapeutics plc (ITRM)
Daewoong Pharmaceutical
Aurobindo Pharma Ltd
Sumitomo Pharma
Pfizer Inc.
Segment by Type
Doripenem
Ertapenem
Imipenem
Meropenem
Panipenem
Biapenem
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbapenem Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbapenem Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Carbapenem Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carbapenem Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carbapenem Drugs include Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical and Hospira Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem Drugs.
Report Scope
The Carbapenem Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shandong New Era Pharmaceutical
Shenzhen Haibin Pharmaceutical
Sinopharm Guorui Pharmaceutical
Taiwan Biotech Co., Ltd.
Merck
Sun Pharmaceutical Industries Ltd.
JW Pharmaceutical
Zhengde Pharmaceutical
Hospira Inc.
WG Critical Care
Hanhui Pharmaceutical
Zhuhai United Laboratories
ACS Dobfar S.p.A
Iterum Therapeutics plc (ITRM)
Daewoong Pharmaceutical
Aurobindo Pharma Ltd
Sumitomo Pharma
Pfizer Inc.
Segment by Type
Doripenem
Ertapenem
Imipenem
Meropenem
Panipenem
Biapenem
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbapenem Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbapenem Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Carbapenem Drugs Market Overview
1.1 Product Overview and Scope of Carbapenem Drugs
1.2 Carbapenem Drugs Segment by Type
1.2.1 Global Carbapenem Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Doripenem
1.2.3 Ertapenem
1.2.4 Imipenem
1.2.5 Meropenem
1.2.6 Panipenem
1.2.7 Biapenem
1.3 Carbapenem Drugs Segment by Application
1.3.1 Global Carbapenem Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Carbapenem Drugs Market Size Estimates and Forecasts
1.4.1 Global Carbapenem Drugs Revenue 2019-2030
1.4.2 Global Carbapenem Drugs Sales 2019-2030
1.4.3 Global Carbapenem Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carbapenem Drugs Market Competition by Manufacturers
2.1 Global Carbapenem Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carbapenem Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carbapenem Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Carbapenem Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carbapenem Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carbapenem Drugs, Product Type & Application
2.7 Carbapenem Drugs Market Competitive Situation and Trends
2.7.1 Carbapenem Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carbapenem Drugs Players Market Share by Revenue
2.7.3 Global Carbapenem Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carbapenem Drugs Retrospective Market Scenario by Region
3.1 Global Carbapenem Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carbapenem Drugs Global Carbapenem Drugs Sales by Region: 2019-2030
3.2.1 Global Carbapenem Drugs Sales by Region: 2019-2024
3.2.2 Global Carbapenem Drugs Sales by Region: 2025-2030
3.3 Global Carbapenem Drugs Global Carbapenem Drugs Revenue by Region: 2019-2030
3.3.1 Global Carbapenem Drugs Revenue by Region: 2019-2024
3.3.2 Global Carbapenem Drugs Revenue by Region: 2025-2030
3.4 North America Carbapenem Drugs Market Facts & Figures by Country
3.4.1 North America Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carbapenem Drugs Sales by Country (2019-2030)
3.4.3 North America Carbapenem Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Carbapenem Drugs Market Facts & Figures by Country
3.5.1 Europe Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carbapenem Drugs Sales by Country (2019-2030)
3.5.3 Europe Carbapenem Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Carbapenem Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carbapenem Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Carbapenem Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Carbapenem Drugs Market Facts & Figures by Country
3.7.1 Latin America Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carbapenem Drugs Sales by Country (2019-2030)
3.7.3 Latin America Carbapenem Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbapenem Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carbapenem Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carbapenem Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Carbapenem Drugs Sales by Type (2019-2030)
4.1.1 Global Carbapenem Drugs Sales by Type (2019-2024)
4.1.2 Global Carbapenem Drugs Sales by Type (2025-2030)
4.1.3 Global Carbapenem Drugs Sales Market Share by Type (2019-2030)
4.2 Global Carbapenem Drugs Revenue by Type (2019-2030)
4.2.1 Global Carbapenem Drugs Revenue by Type (2019-2024)
4.2.2 Global Carbapenem Drugs Revenue by Type (2025-2030)
4.2.3 Global Carbapenem Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Carbapenem Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carbapenem Drugs Sales by Application (2019-2030)
5.1.1 Global Carbapenem Drugs Sales by Application (2019-2024)
5.1.2 Global Carbapenem Drugs Sales by Application (2025-2030)
5.1.3 Global Carbapenem Drugs Sales Market Share by Application (2019-2030)
5.2 Global Carbapenem Drugs Revenue by Application (2019-2030)
5.2.1 Global Carbapenem Drugs Revenue by Application (2019-2024)
5.2.2 Global Carbapenem Drugs Revenue by Application (2025-2030)
5.2.3 Global Carbapenem Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Carbapenem Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shandong New Era Pharmaceutical
6.1.1 Shandong New Era Pharmaceutical Corporation Information
6.1.2 Shandong New Era Pharmaceutical Description and Business Overview
6.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Product Portfolio
6.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.2 Shenzhen Haibin Pharmaceutical
6.2.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.2.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product Portfolio
6.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.3 Sinopharm Guorui Pharmaceutical
6.3.1 Sinopharm Guorui Pharmaceutical Corporation Information
6.3.2 Sinopharm Guorui Pharmaceutical Description and Business Overview
6.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product Portfolio
6.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
6.4 Taiwan Biotech Co., Ltd.
6.4.1 Taiwan Biotech Co., Ltd. Corporation Information
6.4.2 Taiwan Biotech Co., Ltd. Description and Business Overview
6.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product Portfolio
6.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Carbapenem Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product Portfolio
6.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 JW Pharmaceutical Carbapenem Drugs Product Portfolio
6.7.5 JW Pharmaceutical Recent Developments/Updates
6.8 Zhengde Pharmaceutical
6.8.1 Zhengde Pharmaceutical Corporation Information
6.8.2 Zhengde Pharmaceutical Description and Business Overview
6.8.3 Zhengde Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhengde Pharmaceutical Carbapenem Drugs Product Portfolio
6.8.5 Zhengde Pharmaceutical Recent Developments/Updates
6.9 Hospira Inc.
6.9.1 Hospira Inc. Corporation Information
6.9.2 Hospira Inc. Description and Business Overview
6.9.3 Hospira Inc. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hospira Inc. Carbapenem Drugs Product Portfolio
6.9.5 Hospira Inc. Recent Developments/Updates
6.10 WG Critical Care
6.10.1 WG Critical Care Corporation Information
6.10.2 WG Critical Care Description and Business Overview
6.10.3 WG Critical Care Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WG Critical Care Carbapenem Drugs Product Portfolio
6.10.5 WG Critical Care Recent Developments/Updates
6.11 Hanhui Pharmaceutical
6.11.1 Hanhui Pharmaceutical Corporation Information
6.11.2 Hanhui Pharmaceutical Carbapenem Drugs Description and Business Overview
6.11.3 Hanhui Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hanhui Pharmaceutical Carbapenem Drugs Product Portfolio
6.11.5 Hanhui Pharmaceutical Recent Developments/Updates
6.12 Zhuhai United Laboratories
6.12.1 Zhuhai United Laboratories Corporation Information
6.12.2 Zhuhai United Laboratories Carbapenem Drugs Description and Business Overview
6.12.3 Zhuhai United Laboratories Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhuhai United Laboratories Carbapenem Drugs Product Portfolio
6.12.5 Zhuhai United Laboratories Recent Developments/Updates
6.13 ACS Dobfar S.p.A
6.13.1 ACS Dobfar S.p.A Corporation Information
6.13.2 ACS Dobfar S.p.A Carbapenem Drugs Description and Business Overview
6.13.3 ACS Dobfar S.p.A Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ACS Dobfar S.p.A Carbapenem Drugs Product Portfolio
6.13.5 ACS Dobfar S.p.A Recent Developments/Updates
6.14 Iterum Therapeutics plc (ITRM)
6.14.1 Iterum Therapeutics plc (ITRM) Corporation Information
6.14.2 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Description and Business Overview
6.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product Portfolio
6.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
6.15 Daewoong Pharmaceutical
6.15.1 Daewoong Pharmaceutical Corporation Information
6.15.2 Daewoong Pharmaceutical Carbapenem Drugs Description and Business Overview
6.15.3 Daewoong Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Daewoong Pharmaceutical Carbapenem Drugs Product Portfolio
6.15.5 Daewoong Pharmaceutical Recent Developments/Updates
6.16 Aurobindo Pharma Ltd
6.16.1 Aurobindo Pharma Ltd Corporation Information
6.16.2 Aurobindo Pharma Ltd Carbapenem Drugs Description and Business Overview
6.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Product Portfolio
6.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
6.17 Sumitomo Pharma
6.17.1 Sumitomo Pharma Corporation Information
6.17.2 Sumitomo Pharma Carbapenem Drugs Description and Business Overview
6.17.3 Sumitomo Pharma Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sumitomo Pharma Carbapenem Drugs Product Portfolio
6.17.5 Sumitomo Pharma Recent Developments/Updates
6.18 Pfizer Inc.
6.18.1 Pfizer Inc. Corporation Information
6.18.2 Pfizer Inc. Carbapenem Drugs Description and Business Overview
6.18.3 Pfizer Inc. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Pfizer Inc. Carbapenem Drugs Product Portfolio
6.18.5 Pfizer Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbapenem Drugs Industry Chain Analysis
7.2 Carbapenem Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbapenem Drugs Production Mode & Process
7.4 Carbapenem Drugs Sales and Marketing
7.4.1 Carbapenem Drugs Sales Channels
7.4.2 Carbapenem Drugs Distributors
7.5 Carbapenem Drugs Customers
8 Carbapenem Drugs Market Dynamics
8.1 Carbapenem Drugs Industry Trends
8.2 Carbapenem Drugs Market Drivers
8.3 Carbapenem Drugs Market Challenges
8.4 Carbapenem Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Carbapenem Drugs
1.2 Carbapenem Drugs Segment by Type
1.2.1 Global Carbapenem Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Doripenem
1.2.3 Ertapenem
1.2.4 Imipenem
1.2.5 Meropenem
1.2.6 Panipenem
1.2.7 Biapenem
1.3 Carbapenem Drugs Segment by Application
1.3.1 Global Carbapenem Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Carbapenem Drugs Market Size Estimates and Forecasts
1.4.1 Global Carbapenem Drugs Revenue 2019-2030
1.4.2 Global Carbapenem Drugs Sales 2019-2030
1.4.3 Global Carbapenem Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carbapenem Drugs Market Competition by Manufacturers
2.1 Global Carbapenem Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carbapenem Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carbapenem Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Carbapenem Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carbapenem Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carbapenem Drugs, Product Type & Application
2.7 Carbapenem Drugs Market Competitive Situation and Trends
2.7.1 Carbapenem Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carbapenem Drugs Players Market Share by Revenue
2.7.3 Global Carbapenem Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carbapenem Drugs Retrospective Market Scenario by Region
3.1 Global Carbapenem Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carbapenem Drugs Global Carbapenem Drugs Sales by Region: 2019-2030
3.2.1 Global Carbapenem Drugs Sales by Region: 2019-2024
3.2.2 Global Carbapenem Drugs Sales by Region: 2025-2030
3.3 Global Carbapenem Drugs Global Carbapenem Drugs Revenue by Region: 2019-2030
3.3.1 Global Carbapenem Drugs Revenue by Region: 2019-2024
3.3.2 Global Carbapenem Drugs Revenue by Region: 2025-2030
3.4 North America Carbapenem Drugs Market Facts & Figures by Country
3.4.1 North America Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carbapenem Drugs Sales by Country (2019-2030)
3.4.3 North America Carbapenem Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Carbapenem Drugs Market Facts & Figures by Country
3.5.1 Europe Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carbapenem Drugs Sales by Country (2019-2030)
3.5.3 Europe Carbapenem Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Carbapenem Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carbapenem Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Carbapenem Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Carbapenem Drugs Market Facts & Figures by Country
3.7.1 Latin America Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carbapenem Drugs Sales by Country (2019-2030)
3.7.3 Latin America Carbapenem Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbapenem Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbapenem Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carbapenem Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carbapenem Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Carbapenem Drugs Sales by Type (2019-2030)
4.1.1 Global Carbapenem Drugs Sales by Type (2019-2024)
4.1.2 Global Carbapenem Drugs Sales by Type (2025-2030)
4.1.3 Global Carbapenem Drugs Sales Market Share by Type (2019-2030)
4.2 Global Carbapenem Drugs Revenue by Type (2019-2030)
4.2.1 Global Carbapenem Drugs Revenue by Type (2019-2024)
4.2.2 Global Carbapenem Drugs Revenue by Type (2025-2030)
4.2.3 Global Carbapenem Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Carbapenem Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carbapenem Drugs Sales by Application (2019-2030)
5.1.1 Global Carbapenem Drugs Sales by Application (2019-2024)
5.1.2 Global Carbapenem Drugs Sales by Application (2025-2030)
5.1.3 Global Carbapenem Drugs Sales Market Share by Application (2019-2030)
5.2 Global Carbapenem Drugs Revenue by Application (2019-2030)
5.2.1 Global Carbapenem Drugs Revenue by Application (2019-2024)
5.2.2 Global Carbapenem Drugs Revenue by Application (2025-2030)
5.2.3 Global Carbapenem Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Carbapenem Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shandong New Era Pharmaceutical
6.1.1 Shandong New Era Pharmaceutical Corporation Information
6.1.2 Shandong New Era Pharmaceutical Description and Business Overview
6.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Product Portfolio
6.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.2 Shenzhen Haibin Pharmaceutical
6.2.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.2.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product Portfolio
6.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.3 Sinopharm Guorui Pharmaceutical
6.3.1 Sinopharm Guorui Pharmaceutical Corporation Information
6.3.2 Sinopharm Guorui Pharmaceutical Description and Business Overview
6.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product Portfolio
6.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
6.4 Taiwan Biotech Co., Ltd.
6.4.1 Taiwan Biotech Co., Ltd. Corporation Information
6.4.2 Taiwan Biotech Co., Ltd. Description and Business Overview
6.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product Portfolio
6.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Carbapenem Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product Portfolio
6.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 JW Pharmaceutical Carbapenem Drugs Product Portfolio
6.7.5 JW Pharmaceutical Recent Developments/Updates
6.8 Zhengde Pharmaceutical
6.8.1 Zhengde Pharmaceutical Corporation Information
6.8.2 Zhengde Pharmaceutical Description and Business Overview
6.8.3 Zhengde Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhengde Pharmaceutical Carbapenem Drugs Product Portfolio
6.8.5 Zhengde Pharmaceutical Recent Developments/Updates
6.9 Hospira Inc.
6.9.1 Hospira Inc. Corporation Information
6.9.2 Hospira Inc. Description and Business Overview
6.9.3 Hospira Inc. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hospira Inc. Carbapenem Drugs Product Portfolio
6.9.5 Hospira Inc. Recent Developments/Updates
6.10 WG Critical Care
6.10.1 WG Critical Care Corporation Information
6.10.2 WG Critical Care Description and Business Overview
6.10.3 WG Critical Care Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WG Critical Care Carbapenem Drugs Product Portfolio
6.10.5 WG Critical Care Recent Developments/Updates
6.11 Hanhui Pharmaceutical
6.11.1 Hanhui Pharmaceutical Corporation Information
6.11.2 Hanhui Pharmaceutical Carbapenem Drugs Description and Business Overview
6.11.3 Hanhui Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hanhui Pharmaceutical Carbapenem Drugs Product Portfolio
6.11.5 Hanhui Pharmaceutical Recent Developments/Updates
6.12 Zhuhai United Laboratories
6.12.1 Zhuhai United Laboratories Corporation Information
6.12.2 Zhuhai United Laboratories Carbapenem Drugs Description and Business Overview
6.12.3 Zhuhai United Laboratories Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhuhai United Laboratories Carbapenem Drugs Product Portfolio
6.12.5 Zhuhai United Laboratories Recent Developments/Updates
6.13 ACS Dobfar S.p.A
6.13.1 ACS Dobfar S.p.A Corporation Information
6.13.2 ACS Dobfar S.p.A Carbapenem Drugs Description and Business Overview
6.13.3 ACS Dobfar S.p.A Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ACS Dobfar S.p.A Carbapenem Drugs Product Portfolio
6.13.5 ACS Dobfar S.p.A Recent Developments/Updates
6.14 Iterum Therapeutics plc (ITRM)
6.14.1 Iterum Therapeutics plc (ITRM) Corporation Information
6.14.2 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Description and Business Overview
6.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product Portfolio
6.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
6.15 Daewoong Pharmaceutical
6.15.1 Daewoong Pharmaceutical Corporation Information
6.15.2 Daewoong Pharmaceutical Carbapenem Drugs Description and Business Overview
6.15.3 Daewoong Pharmaceutical Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Daewoong Pharmaceutical Carbapenem Drugs Product Portfolio
6.15.5 Daewoong Pharmaceutical Recent Developments/Updates
6.16 Aurobindo Pharma Ltd
6.16.1 Aurobindo Pharma Ltd Corporation Information
6.16.2 Aurobindo Pharma Ltd Carbapenem Drugs Description and Business Overview
6.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Product Portfolio
6.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
6.17 Sumitomo Pharma
6.17.1 Sumitomo Pharma Corporation Information
6.17.2 Sumitomo Pharma Carbapenem Drugs Description and Business Overview
6.17.3 Sumitomo Pharma Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sumitomo Pharma Carbapenem Drugs Product Portfolio
6.17.5 Sumitomo Pharma Recent Developments/Updates
6.18 Pfizer Inc.
6.18.1 Pfizer Inc. Corporation Information
6.18.2 Pfizer Inc. Carbapenem Drugs Description and Business Overview
6.18.3 Pfizer Inc. Carbapenem Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Pfizer Inc. Carbapenem Drugs Product Portfolio
6.18.5 Pfizer Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbapenem Drugs Industry Chain Analysis
7.2 Carbapenem Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbapenem Drugs Production Mode & Process
7.4 Carbapenem Drugs Sales and Marketing
7.4.1 Carbapenem Drugs Sales Channels
7.4.2 Carbapenem Drugs Distributors
7.5 Carbapenem Drugs Customers
8 Carbapenem Drugs Market Dynamics
8.1 Carbapenem Drugs Industry Trends
8.2 Carbapenem Drugs Market Drivers
8.3 Carbapenem Drugs Market Challenges
8.4 Carbapenem Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Carbapenem Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Carbapenem Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Carbapenem Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Carbapenem Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Carbapenem Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Carbapenem Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Carbapenem Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Carbapenem Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Carbapenem Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carbapenem Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carbapenem Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Carbapenem Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbapenem Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbapenem Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Carbapenem Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Carbapenem Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Carbapenem Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Carbapenem Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Carbapenem Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Carbapenem Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Carbapenem Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Carbapenem Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Carbapenem Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Carbapenem Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Carbapenem Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Carbapenem Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Carbapenem Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Carbapenem Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Carbapenem Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Carbapenem Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Carbapenem Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Carbapenem Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Carbapenem Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Carbapenem Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Carbapenem Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Carbapenem Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Carbapenem Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Carbapenem Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Carbapenem Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Carbapenem Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Carbapenem Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Carbapenem Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Carbapenem Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Carbapenem Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Carbapenem Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Carbapenem Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Carbapenem Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Shandong New Era Pharmaceutical Corporation Information
Table 71. Shandong New Era Pharmaceutical Description and Business Overview
Table 72. Shandong New Era Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shandong New Era Pharmaceutical Carbapenem Drugs Product
Table 74. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 75. Shenzhen Haibin Pharmaceutical Corporation Information
Table 76. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 77. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product
Table 79. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 80. Sinopharm Guorui Pharmaceutical Corporation Information
Table 81. Sinopharm Guorui Pharmaceutical Description and Business Overview
Table 82. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product
Table 84. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 85. Taiwan Biotech Co., Ltd. Corporation Information
Table 86. Taiwan Biotech Co., Ltd. Description and Business Overview
Table 87. Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product
Table 89. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Merck Carbapenem Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 96. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product
Table 99. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. JW Pharmaceutical Corporation Information
Table 101. JW Pharmaceutical Description and Business Overview
Table 102. JW Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. JW Pharmaceutical Carbapenem Drugs Product
Table 104. JW Pharmaceutical Recent Developments/Updates
Table 105. Zhengde Pharmaceutical Corporation Information
Table 106. Zhengde Pharmaceutical Description and Business Overview
Table 107. Zhengde Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zhengde Pharmaceutical Carbapenem Drugs Product
Table 109. Zhengde Pharmaceutical Recent Developments/Updates
Table 110. Hospira Inc. Corporation Information
Table 111. Hospira Inc. Description and Business Overview
Table 112. Hospira Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hospira Inc. Carbapenem Drugs Product
Table 114. Hospira Inc. Recent Developments/Updates
Table 115. WG Critical Care Corporation Information
Table 116. WG Critical Care Description and Business Overview
Table 117. WG Critical Care Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. WG Critical Care Carbapenem Drugs Product
Table 119. WG Critical Care Recent Developments/Updates
Table 120. Hanhui Pharmaceutical Corporation Information
Table 121. Hanhui Pharmaceutical Description and Business Overview
Table 122. Hanhui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hanhui Pharmaceutical Carbapenem Drugs Product
Table 124. Hanhui Pharmaceutical Recent Developments/Updates
Table 125. Zhuhai United Laboratories Corporation Information
Table 126. Zhuhai United Laboratories Description and Business Overview
Table 127. Zhuhai United Laboratories Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Zhuhai United Laboratories Carbapenem Drugs Product
Table 129. Zhuhai United Laboratories Recent Developments/Updates
Table 130. ACS Dobfar S.p.A Corporation Information
Table 131. ACS Dobfar S.p.A Description and Business Overview
Table 132. ACS Dobfar S.p.A Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ACS Dobfar S.p.A Carbapenem Drugs Product
Table 134. ACS Dobfar S.p.A Recent Developments/Updates
Table 135. Iterum Therapeutics plc (ITRM) Corporation Information
Table 136. Iterum Therapeutics plc (ITRM) Description and Business Overview
Table 137. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product
Table 139. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 140. Daewoong Pharmaceutical Corporation Information
Table 141. Daewoong Pharmaceutical Description and Business Overview
Table 142. Daewoong Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Daewoong Pharmaceutical Carbapenem Drugs Product
Table 144. Daewoong Pharmaceutical Recent Developments/Updates
Table 145. Aurobindo Pharma Ltd Corporation Information
Table 146. Aurobindo Pharma Ltd Description and Business Overview
Table 147. Aurobindo Pharma Ltd Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Aurobindo Pharma Ltd Carbapenem Drugs Product
Table 149. Aurobindo Pharma Ltd Recent Developments/Updates
Table 150. Sumitomo Pharma Corporation Information
Table 151. Sumitomo Pharma Description and Business Overview
Table 152. Sumitomo Pharma Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Sumitomo Pharma Carbapenem Drugs Product
Table 154. Sumitomo Pharma Recent Developments/Updates
Table 155. Pfizer Inc. Corporation Information
Table 156. Pfizer Inc. Description and Business Overview
Table 157. Pfizer Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Pfizer Inc. Carbapenem Drugs Product
Table 159. Pfizer Inc. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Carbapenem Drugs Distributors List
Table 163. Carbapenem Drugs Customers List
Table 164. Carbapenem Drugs Market Trends
Table 165. Carbapenem Drugs Market Drivers
Table 166. Carbapenem Drugs Market Challenges
Table 167. Carbapenem Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carbapenem Drugs
Figure 2. Global Carbapenem Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Carbapenem Drugs Market Share by Type in 2023 & 2030
Figure 4. Doripenem Product Picture
Figure 5. Ertapenem Product Picture
Figure 6. Imipenem Product Picture
Figure 7. Meropenem Product Picture
Figure 8. Panipenem Product Picture
Figure 9. Biapenem Product Picture
Figure 10. Global Carbapenem Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Carbapenem Drugs Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Carbapenem Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Carbapenem Drugs Market Size (2019-2030) & (US$ Million)
Figure 17. Global Carbapenem Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Carbapenem Drugs Average Price (US$/Unit) & (2019-2030)
Figure 19. Carbapenem Drugs Report Years Considered
Figure 20. Carbapenem Drugs Sales Share by Manufacturers in 2023
Figure 21. Global Carbapenem Drugs Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Carbapenem Drugs Players: Market Share by Revenue in 2023
Figure 23. Carbapenem Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Carbapenem Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 26. North America Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 27. United States Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 30. Europe Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 31. Germany Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Netherlands Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Carbapenem Drugs Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Carbapenem Drugs Revenue Market Share by Region (2019-2030)
Figure 38. China Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Carbapenem Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Carbapenem Drugs by Type (2019-2030)
Figure 57. Global Carbapenem Drugs Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Carbapenem Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Carbapenem Drugs by Application (2019-2030)
Figure 60. Global Carbapenem Drugs Price (US$/Unit) by Application (2019-2030)
Figure 61. Carbapenem Drugs Value Chain
Figure 62. Carbapenem Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Carbapenem Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Carbapenem Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Carbapenem Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Carbapenem Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Carbapenem Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Carbapenem Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Carbapenem Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Carbapenem Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Carbapenem Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carbapenem Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carbapenem Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Carbapenem Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbapenem Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbapenem Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Carbapenem Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Carbapenem Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Carbapenem Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Carbapenem Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Carbapenem Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Carbapenem Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Carbapenem Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Carbapenem Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Carbapenem Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Carbapenem Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Carbapenem Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Carbapenem Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Carbapenem Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Carbapenem Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Carbapenem Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Carbapenem Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Carbapenem Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Carbapenem Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Carbapenem Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Carbapenem Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Carbapenem Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Carbapenem Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Carbapenem Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Carbapenem Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Carbapenem Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Carbapenem Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Carbapenem Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Carbapenem Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Carbapenem Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Carbapenem Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Carbapenem Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Carbapenem Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Carbapenem Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Carbapenem Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Carbapenem Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Carbapenem Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Carbapenem Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Carbapenem Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Shandong New Era Pharmaceutical Corporation Information
Table 71. Shandong New Era Pharmaceutical Description and Business Overview
Table 72. Shandong New Era Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shandong New Era Pharmaceutical Carbapenem Drugs Product
Table 74. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 75. Shenzhen Haibin Pharmaceutical Corporation Information
Table 76. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 77. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product
Table 79. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 80. Sinopharm Guorui Pharmaceutical Corporation Information
Table 81. Sinopharm Guorui Pharmaceutical Description and Business Overview
Table 82. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product
Table 84. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 85. Taiwan Biotech Co., Ltd. Corporation Information
Table 86. Taiwan Biotech Co., Ltd. Description and Business Overview
Table 87. Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product
Table 89. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Merck Carbapenem Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 96. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product
Table 99. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. JW Pharmaceutical Corporation Information
Table 101. JW Pharmaceutical Description and Business Overview
Table 102. JW Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. JW Pharmaceutical Carbapenem Drugs Product
Table 104. JW Pharmaceutical Recent Developments/Updates
Table 105. Zhengde Pharmaceutical Corporation Information
Table 106. Zhengde Pharmaceutical Description and Business Overview
Table 107. Zhengde Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zhengde Pharmaceutical Carbapenem Drugs Product
Table 109. Zhengde Pharmaceutical Recent Developments/Updates
Table 110. Hospira Inc. Corporation Information
Table 111. Hospira Inc. Description and Business Overview
Table 112. Hospira Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hospira Inc. Carbapenem Drugs Product
Table 114. Hospira Inc. Recent Developments/Updates
Table 115. WG Critical Care Corporation Information
Table 116. WG Critical Care Description and Business Overview
Table 117. WG Critical Care Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. WG Critical Care Carbapenem Drugs Product
Table 119. WG Critical Care Recent Developments/Updates
Table 120. Hanhui Pharmaceutical Corporation Information
Table 121. Hanhui Pharmaceutical Description and Business Overview
Table 122. Hanhui Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hanhui Pharmaceutical Carbapenem Drugs Product
Table 124. Hanhui Pharmaceutical Recent Developments/Updates
Table 125. Zhuhai United Laboratories Corporation Information
Table 126. Zhuhai United Laboratories Description and Business Overview
Table 127. Zhuhai United Laboratories Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Zhuhai United Laboratories Carbapenem Drugs Product
Table 129. Zhuhai United Laboratories Recent Developments/Updates
Table 130. ACS Dobfar S.p.A Corporation Information
Table 131. ACS Dobfar S.p.A Description and Business Overview
Table 132. ACS Dobfar S.p.A Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ACS Dobfar S.p.A Carbapenem Drugs Product
Table 134. ACS Dobfar S.p.A Recent Developments/Updates
Table 135. Iterum Therapeutics plc (ITRM) Corporation Information
Table 136. Iterum Therapeutics plc (ITRM) Description and Business Overview
Table 137. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product
Table 139. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 140. Daewoong Pharmaceutical Corporation Information
Table 141. Daewoong Pharmaceutical Description and Business Overview
Table 142. Daewoong Pharmaceutical Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Daewoong Pharmaceutical Carbapenem Drugs Product
Table 144. Daewoong Pharmaceutical Recent Developments/Updates
Table 145. Aurobindo Pharma Ltd Corporation Information
Table 146. Aurobindo Pharma Ltd Description and Business Overview
Table 147. Aurobindo Pharma Ltd Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Aurobindo Pharma Ltd Carbapenem Drugs Product
Table 149. Aurobindo Pharma Ltd Recent Developments/Updates
Table 150. Sumitomo Pharma Corporation Information
Table 151. Sumitomo Pharma Description and Business Overview
Table 152. Sumitomo Pharma Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Sumitomo Pharma Carbapenem Drugs Product
Table 154. Sumitomo Pharma Recent Developments/Updates
Table 155. Pfizer Inc. Corporation Information
Table 156. Pfizer Inc. Description and Business Overview
Table 157. Pfizer Inc. Carbapenem Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Pfizer Inc. Carbapenem Drugs Product
Table 159. Pfizer Inc. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Carbapenem Drugs Distributors List
Table 163. Carbapenem Drugs Customers List
Table 164. Carbapenem Drugs Market Trends
Table 165. Carbapenem Drugs Market Drivers
Table 166. Carbapenem Drugs Market Challenges
Table 167. Carbapenem Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carbapenem Drugs
Figure 2. Global Carbapenem Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Carbapenem Drugs Market Share by Type in 2023 & 2030
Figure 4. Doripenem Product Picture
Figure 5. Ertapenem Product Picture
Figure 6. Imipenem Product Picture
Figure 7. Meropenem Product Picture
Figure 8. Panipenem Product Picture
Figure 9. Biapenem Product Picture
Figure 10. Global Carbapenem Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Carbapenem Drugs Market Share by Application in 2023 & 2030
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Carbapenem Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Carbapenem Drugs Market Size (2019-2030) & (US$ Million)
Figure 17. Global Carbapenem Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Carbapenem Drugs Average Price (US$/Unit) & (2019-2030)
Figure 19. Carbapenem Drugs Report Years Considered
Figure 20. Carbapenem Drugs Sales Share by Manufacturers in 2023
Figure 21. Global Carbapenem Drugs Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Carbapenem Drugs Players: Market Share by Revenue in 2023
Figure 23. Carbapenem Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Carbapenem Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 26. North America Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 27. United States Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 30. Europe Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 31. Germany Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Netherlands Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Carbapenem Drugs Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Carbapenem Drugs Revenue Market Share by Region (2019-2030)
Figure 38. China Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Carbapenem Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Carbapenem Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Carbapenem Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Carbapenem Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Carbapenem Drugs by Type (2019-2030)
Figure 57. Global Carbapenem Drugs Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Carbapenem Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Carbapenem Drugs by Application (2019-2030)
Figure 60. Global Carbapenem Drugs Price (US$/Unit) by Application (2019-2030)
Figure 61. Carbapenem Drugs Value Chain
Figure 62. Carbapenem Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232